Discover why the Netherlands is a leading hub for biotech clinical trials, with unique advantages, challenges, and strong ...

The paper mill was discovered by the research-integrity sleuth and scientist Anna Abalkina at the Free University of Berlin ...

The WHO has added GLP-1 agonists to its Essential Medicines List in 2025. Learn more about the impact of this decision.

At the European Cell & Gene Therapy Summit 2025, funding challenges and innovation drove discussions on the sector’s future.

Gene therapies have seen a drop in investor interest lately. Despite this, Kriya Therapeutics seems to be attracting funds in ...

Discover how in some communities around the world, the prevalence of rare diseases is higher due to factors like cousin ...

Discover the top biotech deals of August 2025, as several big pharmas shopped around, especially in the field of small ...

Nature writes the best horror stories – In The New York Times’ recent piece, the return of the screwworm, a flesh‑eating parasite once eradicated from the U.S. Indeed, cattle ranchers are once again ...

Irish biotech Alkermes was the most recent to report encouraging results in the clinic. Its drug candidate alixorexton addresses orexin deficiencies. Orexin is a neuropeptide – a chemical messenger ...

The news that the organization led a $35 million funding round for London-based Portal Biotech came about two weeks ago. Portal Biotech’s focus is on the field of proteomics, which is the study of ...

Antibody therapies constitute a vast global market: currently valued at over $250 billion, the market for antibodies is expected to exceed $850 billion worldwide by 2032. Driving forces behind this ...